136 related articles for article (PubMed ID: 33728887)
1. Prescription medication use among Canadian children and youth, 2012 to 2017.
Servais J; Ramage-Morin PL; Gal J; Hales CM
Health Rep; 2021 Mar; 32(3):3-16. PubMed ID: 33728887
[TBL] [Abstract][Full Text] [Related]
2. Trends in Prescription Medication Use Among Children and Adolescents-United States, 1999-2014.
Hales CM; Kit BK; Gu Q; Ogden CL
JAMA; 2018 May; 319(19):2009-2020. PubMed ID: 29800213
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007.
Brault MC; Lacourse É
Can J Psychiatry; 2012 Feb; 57(2):93-101. PubMed ID: 22340149
[TBL] [Abstract][Full Text] [Related]
4. Medical use and misuse of psychoactive prescription medications among US youth and young adults.
Agaku I; Odani S; Nelson J
Fam Med Community Health; 2021 Jan; 9(1):. PubMed ID: 33536180
[TBL] [Abstract][Full Text] [Related]
5. Unfilled Prescriptions of Medicare Beneficiaries: Prevalence, Reasons, and Types of Medicines Prescribed.
Kennedy J; Tuleu I; Mackay K
J Manag Care Spec Pharm; 2020 Aug; 26(8):935-942. PubMed ID: 32715958
[TBL] [Abstract][Full Text] [Related]
6. Use of medication and psychological counselling among Canadians with mood and/or anxiety disorders.
O'Donnell S; Syoufi M; Jones W; Bennett K; Pelletier L
Health Promot Chronic Dis Prev Can; 2017 May; 37(5):160-171. PubMed ID: 28493660
[TBL] [Abstract][Full Text] [Related]
7. Prescription medication use by Canadians aged 6 to 79.
Rotermann M; Sanmartin C; Hennessy D; Arthur M
Health Rep; 2014 Jun; 25(6):3-9. PubMed ID: 24941315
[TBL] [Abstract][Full Text] [Related]
8. Prescription of methylphenidate to children and youth, 1990-1996.
Miller AR; Lalonde CE; McGrail KM; Armstrong RW
CMAJ; 2001 Nov; 165(11):1489-94. PubMed ID: 11762572
[TBL] [Abstract][Full Text] [Related]
9. Off-Label Prescribing for Children with Migraines in U.S. Ambulatory Care Settings.
Lai LL; Koh L; Ho JA; Ting A; Obi A
J Manag Care Spec Pharm; 2017 Mar; 23(3):382-387. PubMed ID: 28230456
[TBL] [Abstract][Full Text] [Related]
10. Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008.
Gu Q; Dillon CF; Burt VL
NCHS Data Brief; 2010 Sep; (42):1-8. PubMed ID: 20854747
[TBL] [Abstract][Full Text] [Related]
11. Drug trends among non-institutionalized Canadians and the impact of data collection changes in the Canadian Health Measures Survey 2007 to 2015.
Chao YS; Wu CJ; Wu HC; Chen WC
PLoS One; 2019; 14(4):e0214718. PubMed ID: 30978234
[TBL] [Abstract][Full Text] [Related]
12. Prescribing of asthma medication in primary care for children aged under 10.
Schokker S; Groenhof F; van der Veen WJ; van der Molen T
Prim Care Respir J; 2010 Mar; 19(1):28-34. PubMed ID: 19662320
[TBL] [Abstract][Full Text] [Related]
13. Medication costs to private insurers of diversion of medications for attention-deficit hyperactivity disorder.
Aldridge AP; Kroutil LA; Cowell AJ; Reeves DB; Van Brunt DL
Pharmacoeconomics; 2011 Jul; 29(7):621-35. PubMed ID: 21473655
[TBL] [Abstract][Full Text] [Related]
14. Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015.
Renoux C; Shin JY; Dell'Aniello S; Fergusson E; Suissa S
Br J Clin Pharmacol; 2016 Sep; 82(3):858-68. PubMed ID: 27145886
[TBL] [Abstract][Full Text] [Related]
15. Prescription drug dispensing profiles for one million children: a population-based analysis.
Zhang T; Smith MA; Camp PG; Shajari S; MacLeod SM; Carleton BC
Eur J Clin Pharmacol; 2013 Mar; 69(3):581-8. PubMed ID: 22791273
[TBL] [Abstract][Full Text] [Related]
16. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
Visser SN; Lesesne CA; Perou R
Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic Medication Prescription Rates and Trends for New Zealand Children and Adolescents 2008-2016.
Barczyk ZA; Rucklidge JJ; Eggleston M; Mulder RT
J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):87-96. PubMed ID: 31633377
[No Abstract] [Full Text] [Related]
18. A population-based study of prescribing trends in a potentially vulnerable paediatric population from 1999 to 2012.
Sears K; Elms S; Whitehead M; Tranmer JE; Edge DS; VanDenKerkhof EG
Int J Pharm Pract; 2019 Dec; 27(6):545-554. PubMed ID: 31373071
[TBL] [Abstract][Full Text] [Related]
19. Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
Feroe AG; Uppal N; Gutiérrez-Sacristán A; Mousavi S; Greenspun P; Surati R; Kohane IS; Avillach P
JAMA Pediatr; 2021 Sep; 175(9):957-965. PubMed ID: 34097007
[TBL] [Abstract][Full Text] [Related]
20. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.
Rushton JL; Clark SJ; Freed GL
Pediatrics; 2000 Jun; 105(6):E82. PubMed ID: 10835095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
